Global Interventional Cardiology Devices Market: Key Developments
Major players in the global interventional cardiology devices market are focused on R&D to expand their product portfolio. For instance, in July 2019, SINOMED completed enrollment in the PIONEER III randomized, controlled clinical trial to assess the safety and effectiveness of the BuMA Supreme DES in order to obtain key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients